The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Serum HE4 marker for recurrent endometrial cancer

takingcontrol58
takingcontrol58 CSN Member Posts: 279 Member
edited December 2017 in Uterine/Endometrial Cancer #1

I know many people on this board are not being measured for serum HE4 or their doctors may not 
be familiar with it. Both HE4 and CA125 are blood markers for endometrial cancer. I am tested for
both markers as part of my ongoing follow-up treatment.

Below is an article published by the NIH that explains what this marker is and its effectiveness
in being used to detect recurrent disease of endometrial adenocarcinoma. 

"Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance"
February 2015


www.pubmed.gov

PMID 25655024

 

Takingcontrol58

 

 

 

 

Like Care

Comments

  • oldbeauty
    oldbeauty CSN Member Posts: 389 Member
    #2
    Thank you

    Takingcontrol, thank you for posting this.  I intend to read it, and there is another publication of interest to me that cites your article that appears to discuss HE4 as an aid to evaluating progestin receptor status post-hormone therapy.  It is publication 5023780 (to the best of my knowledge). Best wishes, Oldbeauty

    Like Care

Discussion Boards